Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Madhav R. Seshadri & Ari M. Melnick. (2022) Targeting MALT1 for the treatment of diffuse large B-cell lymphoma. Leukemia & Lymphoma 63:4, pages 789-798.
Read now
Read now
John R Jones, Charlotte Pawlyn & Graham H Jackson. (2021) Safety of lenalidomide for maintenance treatment of patients with multiple myeloma following autologous stem cell transplantation. Expert Opinion on Drug Safety 20:10, pages 1137-1145.
Read now
Read now
Albert Oriol. (2020) A critical evaluation of pembrolizumab in addition to lenalidomide and dexamethasone for the treatment of multiple myeloma. Expert Review of Hematology 13:5, pages 435-445.
Read now
Read now
Fabienne Lampert, Mia M. L. Brodersen & Matthias Peter. (2017) Guard the guardian: A CRL4 ligase stands watch over histone production. Nucleus 8:2, pages 134-143.
Read now
Read now
J. R. Jones, C. Pawlyn, F. E. Davies & G. J. Morgan. (2016) The safety of pomalidomide for the treatment of multiple myeloma. Expert Opinion on Drug Safety 15:4, pages 535-547.
Read now
Read now
Articles from other publishers (46)
Tongdong Shi, Zaoxiu Hu, Li Tian & Yanlong Yang. (2023) Advances in lung adenocarcinoma: A novel perspective on prognoses and immune responses of CENPO as an oncogenic superenhancer. Translational Oncology 34, pages 101691.
Crossref
Crossref
Zhen-Ling Liu, Huan-Huan Chen, Li-Li Zheng, Li-Ping Sun & Lei Shi. (2023) Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Lara J. Bou Malhab, Habiba Alsafar, Saleh Ibrahim & Mohamed Rahmani. (2023) PROTACs: Walking through hematological malignancies. Frontiers in Pharmacology 14.
Crossref
Crossref
Hyeun-Wook Chang, Kyeong-Hwa Sim & Youn-Ju Lee. (2023) Thalidomide Attenuates Mast Cell Activation by Upregulating SHP-1 Signaling and Interfering with the Action of CRBN. Cells 12:3, pages 469.
Crossref
Crossref
Hanley N. Abramson. (2023) Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma. International Journal of Molecular Sciences 24:3, pages 2645.
Crossref
Crossref
Changchang Meng, Shiyu Chen, Qi. He, Junyi Tan, Jingxian Wu & Jing Zhao. (2023) IKZF3 modulates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation. International Immunopharmacology 114, pages 109480.
Crossref
Crossref
Elio Nushi, Victor‐Bogdan Popescu, Jose‐Angel Sanchez Martin, Sergiu Ivanov, Eugen Czeizler & Ion Petre. 2022. Systems Biology Modelling and Analysis. Systems Biology Modelling and Analysis
363
423
.
Zhi Lin, Dacheng Shen, Bo Yang & Christina M. Woo. (2022) Molecular and Structural Characterization of Lenalidomide-Mediated Sequestration of eIF3i. ACS Chemical Biology 17:11, pages 3229-3237.
Crossref
Crossref
Hao Guo, Jingyi Yang, Haoran Wang, Xingchen Liu, Yanyan Liu & Keshu Zhou. (2022) Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms. Frontiers in Immunology 13.
Crossref
Crossref
Jiao-li Ma, Xu-ming Zhou, Jia-lin Chen, Jie-xin Shi, Hui-cheng Cheng, Peng-hu Guo & Hong-bing Ji. (2022) Directing group strategies in rhodium-catalyzed C–H amination. Organic & Biomolecular Chemistry 20:38, pages 7554-7576.
Crossref
Crossref
Cheng-Liang Zhu, Xiaomin Luo, Tian Tian, Zijian Rao, Hanlin Wang, Zhesheng Zhou, Tian Mi, Danni Chen, Yongjin Xu, Yizhe Wu, Jinxin Che, Yubo Zhou, Jia Li & Xiaowu Dong. (2022) Structure-based rational design enables efficient discovery of a new selective and potent AKT PROTAC degrader. European Journal of Medicinal Chemistry 238, pages 114459.
Crossref
Crossref
Alessandra Salerno, Francesca Seghetti, Jessica Caciolla, Elisa Uliassi, Eleonora Testi, Melissa Guardigni, Marinella Roberti, Andrea Milelli & Maria Laura Bolognesi. (2022) Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One. Journal of Medicinal Chemistry 65:14, pages 9507-9530.
Crossref
Crossref
S. V. Semochkin. (2022) Mechanisms of action of immunomodulatory drugs — from teratogenicity to treatment of multiple myeloma. Russian journal of hematology and transfusiology 67:2, pages 240-260.
Crossref
Crossref
Jiao‐Li Ma, Xu‐Ming Zhou, Peng‐Hu Guo, Hui‐Cheng Cheng & Hong‐bing Ji. (2022)
Copper‐Mediated
and Catalyzed C—H Bond Amination via Chelation Assistance: Scope, Mechanism and Synthetic Applications
. Chinese Journal of Chemistry 40:10, pages 1204-1223.
Crossref
Crossref
David A. Frank. (2022) Cyclin-Dependent Kinase 4/6 Inhibitors: Is a Noncanonical Substrate the Key Target?. Cancer Research 82:7, pages 1170-1171.
Crossref
Crossref
Adam S. Sperling & Kenneth C. Anderson. (2021) Facts and Hopes in Multiple Myeloma Immunotherapy. Clinical Cancer Research 27:16, pages 4468-4477.
Crossref
Crossref
Erin W. Meermeier, Seth J. Welsh, Meaghen E. Sharik, Megan T. Du, Victoria M. Garbitt, Daniel L. Riggs, Chang-Xin Shi, Caleb K. Stein, Marco Bergsagel, Bryant Chau, Matthew L. Wheeler, Natalie Bezman, Feng Wang, Pavel Strop, P. Leif Bergsagel & Marta Chesi. (2021) Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy. Blood Cancer Discovery 2:4, pages 354-369.
Crossref
Crossref
Andrew X. Zhang, Katelyn Cassidy, Göran Dahl, Kevin Moreau, Fiona Pachl & Andrea M. Zuhl. (2021) The Vital Role of Proteomics in Characterizing Novel Protein Degraders. SLAS Discovery 26:4, pages 518-523.
Crossref
Crossref
Alexey L. Chernobrovkin, Cindy Cázares-Körner, Tomas Friman, Isabel Martin Caballero, Daniele Amadio & Daniel Martinez Molina. (2021) A Tale of Two Tails: Efficient Profiling of Protein Degraders by Specific Functional and Target Engagement Readouts. SLAS Discovery 26:4, pages 534-546.
Crossref
Crossref
Sandeep Kumar, Sunil Kumar Singh, Basabi Rana & Ajay Rana. (2021) Tumor-infiltrating CD8+ T cell antitumor efficacy and exhaustion: molecular insights. Drug Discovery Today 26:4, pages 951-967.
Crossref
Crossref
Marco Cippitelli, Helena Stabile, Andrea Kosta, Sara Petillo, Angela Gismondi, Angela Santoni & Cinzia Fionda. (2021) Role of Aiolos and Ikaros in the Antitumor and Immunomodulatory Activity of IMiDs in Multiple Myeloma: Better to Lose Than to Find Them. International Journal of Molecular Sciences 22:3, pages 1103.
Crossref
Crossref
Linda Röhner, Yuen Lam Dora Ng, Annika Scheffold, Stefanie Lindner, Simon Köpff, Andreas Brandl, Andreas Beilhack & Jan Krönke. (2021) Generation of a lenalidomide-sensitive syngeneic murine in vivo multiple myeloma model by expression of Crbn. Experimental Hematology 93, pages 61-69.e4.
Crossref
Crossref
Tao Wu, Hojong Yoon, Yuan Xiong, Sarah E. Dixon-Clarke, Radosław P. Nowak & Eric S. Fischer. (2020) Targeted protein degradation as a powerful research tool in basic biology and drug target discovery. Nature Structural & Molecular Biology 27:7, pages 605-614.
Crossref
Crossref
Tomoko Asatsuma-Okumura, Takumi Ito & Hiroshi Handa. (2020) Molecular Mechanisms of the Teratogenic Effects of Thalidomide. Pharmaceuticals 13:5, pages 95.
Crossref
Crossref
Kazuhito Suzuki, Kaichi Nishiwaki, Tadahiro Gunji, Mitsuji Katori, Hidekazu Masuoka & Shingo Yano. (2020) Elevated eosinophil level predicted long time to next treatment in relapsed or refractory myeloma patients treated with lenalidomide. Cancer Medicine 9:5, pages 1694-1702.
Crossref
Crossref
Sandra Domingo, Cristina Solé, Teresa Moliné, Berta Ferrer, Josep Ordi-Ros & Josefina Cortés-Hernández. (2020) Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms. Dermatology 236:5, pages 467-476.
Crossref
Crossref
Inchul You, Emily C. Erickson, Katherine A. Donovan, Nicholas A. Eleuteri, Eric S. Fischer, Nathanael S. Gray & Alex Toker. (2020) Discovery of an AKT Degrader with Prolonged Inhibition of Downstream Signaling. Cell Chemical Biology 27:1, pages 66-73.e7.
Crossref
Crossref
Zhengnian Li, Benika J. Pinch, Calla M. Olson, Katherine A. Donovan, Radosław P. Nowak, Caitlin E. Mills, David A. Scott, Zainab M. Doctor, Nicholas A. Eleuteri, Mirra Chung, Peter K. Sorger, Eric S. Fischer & Nathanael S. Gray. (2020) Development and Characterization of a Wee1 Kinase Degrader. Cell Chemical Biology 27:1, pages 57-65.e9.
Crossref
Crossref
Anil Kumar Tomar, Rahul Agarwal & Bishwajit Kundu. (2019) Most Variable Genes and Transcription Factors in Acute Lymphoblastic Leukemia Patients. Interdisciplinary Sciences: Computational Life Sciences 11:4, pages 668-678.
Crossref
Crossref
Christopher Heim, Dimanthi Pliatsika, Farnoush Mousavizadeh, Kerstin Bär, Birte Hernandez Alvarez, Athanassios Giannis & Marcus D. Hartmann. (2019) De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives. Journal of Medicinal Chemistry 62:14, pages 6615-6629.
Crossref
Crossref
Ji Cheng, Jianping Guo, Brian J. North, Kaixiong Tao, Pengbo Zhou & Wenyi Wei. (2019) The emerging role for Cullin 4 family of E3 ligases in tumorigenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1871:1, pages 138-159.
Crossref
Crossref
Federica Costa, Rituparna Das, Jithendra Kini Bailur, Kavita Dhodapkar & Madhav V. Dhodapkar. (2018) Checkpoint Inhibition in Myeloma: Opportunities and Challenges. Frontiers in Immunology 9.
Crossref
Crossref
Sang-Min Jang, Christophe E. Redon & Mirit I. Aladjem. (2018) Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy. Frontiers in Molecular Biosciences 5.
Crossref
Crossref
Franziska La Meir, Tobias Boch, Daniel Nowak, Georgia Metzgeroth & Wolf-Karsten Hofmann. 2018. Geriatrische Onkologie. Geriatrische Onkologie
183
197
.
Elisabeth Bertrand, Nathalie Jouy, Salomon Manier, Guillemette Fouquet, Stéphanie Guidez, Eileen Boyle, Stéphanie Noel, Cécile Tomowiak, Charles Herbaux, Susanna Schraen, Claude Preudhomme, Bruno Quesnel, Stéphanie Poulain & Xavier Leleu. (2017) Role of IRF4 in resistance to immunomodulatory (IMid) compounds® in Waldenström’s macroglobulinemia. Oncotarget 8:68, pages 112917-112927.
Crossref
Crossref
Julie L. Mitchell, Amara Seng & Thomas M. Yankee. (2017) Expression and splicing of Ikaros family members in murine and human thymocytes. Molecular Immunology 87, pages 1-11.
Crossref
Crossref
Aviad Tsherniak, Francisca Vazquez, Phil G. Montgomery, Barbara A. Weir, Gregory Kryukov, Glenn S. Cowley, Stanley Gill, William F. Harrington, Sasha Pantel, John M. Krill-Burger, Robin M. Meyers, Levi Ali, Amy Goodale, Yenarae Lee, Guozhi Jiang, Jessica Hsiao, William F.J. Gerath, Sara Howell, Erin Merkel, Mahmoud Ghandi, Levi A. Garraway, David E. Root, Todd R. Golub, Jesse S. Boehm & William C. Hahn. (2017) Defining a Cancer Dependency Map. Cell 170:3, pages 564-576.e16.
Crossref
Crossref
Katia Georgopoulos. (2017) The making of a lymphocyte: the choice among disparate cell fates and the IKAROS enigma. Genes & Development 31:5, pages 439-450.
Crossref
Crossref
Qinglin Shi & Lijuan Chen. (2017) Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as well as Cell Metabolism and Disease Generation. Journal of Immunology Research 2017, pages 1-8.
Crossref
Crossref
Amer M. Zeidan, B. Douglas Smith, Hetty E. Carraway, Ivana Gojo, Amy DeZern & Steven D. Gore. (2016) A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher‐risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia. British Journal of Haematology 176:2, pages 241-247.
Crossref
Crossref
Franziska La Meir, Tobias Boch, Daniel Nowak, Georgia Metzgeroth & Wolf-Karsten Hofmann. 2017. Geriatrische Onkologie. Geriatrische Onkologie
1
15
.
Sunil Singhal, Pratik S. Bhojnagarwala, Shaun O'Brien, Edmund K. Moon, Alfred L. Garfall, Abhishek S. Rao, Jon G. Quatromoni, Tom Li Stephen, Leslie Litzky, Charuhas Deshpande, Michael D. Feldman, Wayne W. Hancock, Jose R. Conejo-Garcia, Steven M. Albelda & Evgeniy B. Eruslanov. (2016) Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer. Cancer Cell 30:1, pages 120-135.
Crossref
Crossref
Yun Dai & Fengyan Jin. (2016) Novel mechanisms of action for immunomodulatory drugs (IMiDs) against multiple myeloma: from a tragedy to a therapy. INTERNATIONAL JOURNAL OF HEMATOLOGY AND THERAPY 2:1, pages 1-6.
Crossref
Crossref
Jeffrey Hannah & Pengbo Zhou. (2015) Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B. Gene 573:1, pages 33-45.
Crossref
Crossref
Valeria Santini. (2015) Anemia as the Main Manifestation of Myelodysplastic Syndromes. Seminars in Hematology 52:4, pages 348-356.
Crossref
Crossref
Alessia Errico. (2013) Ikaros—not a myth for myeloma. Nature Reviews Clinical Oncology 11:2, pages 65-65.
Crossref
Crossref